Published in Semin Oncol on April 01, 2012
Vemurafenib: an evidence-based review of its clinical utility in the treatment of metastatic melanoma. Drug Des Devel Ther (2014) 0.91
Dermatologic adverse events in pediatric patients receiving targeted anticancer therapies: a pooled analysis. Pediatr Blood Cancer (2015) 0.83
Oral mucosal changes induced by anticancer targeted therapies and immune checkpoint inhibitors. Support Care Cancer (2017) 0.75
Pigmentary changes in patients treated with targeted anticancer agents: A systematic review and meta-analysis. J Am Acad Dermatol (2017) 0.75
Safety and tumor responses with lambrolizumab (anti-PD-1) in melanoma. N Engl J Med (2013) 18.08
Pembrolizumab versus Ipilimumab in Advanced Melanoma. N Engl J Med (2015) 8.64
Keratoacanthomas and squamous cell carcinomas in patients receiving sorafenib. J Clin Oncol (2009) 2.16
The price of tumor control: an analysis of rare side effects of anti-CTLA-4 therapy in metastatic melanoma from the ipilimumab network. PLoS One (2013) 2.01
RAF inhibition and induction of cutaneous squamous cell carcinoma. Curr Opin Oncol (2011) 1.92
Hemophilia A induced by ipilimumab. N Engl J Med (2011) 1.55
Skin tumors induced by sorafenib; paradoxic RAS-RAF pathway activation and oncogenic mutations of HRAS, TP53, and TGFBR1. Clin Cancer Res (2011) 1.52
[Anti-CTLA-4 monoclonal antibody: a major step in the treatment of metastatic melanoma]. Med Sci (Paris) (2011) 1.38
Geographic tongue induced by angiogenesis inhibitors. Oncologist (2013) 1.28
Ctla-4 blockade confers lymphocyte resistance to regulatory T-cells in advanced melanoma: surrogate marker of efficacy of tremelimumab? Clin Cancer Res (2008) 1.21
Sorafenib-induced eruptive melanocytic lesions. Arch Dermatol (2008) 1.21
Rituximab therapy for HIV-associated Castleman disease. Blood (2003) 1.16
Case-control study of cutaneous human papillomaviruses in squamous cell carcinoma of the skin. Cancer Epidemiol Biomarkers Prev (2012) 1.04
Kidney injuries related to ipilimumab. Invest New Drugs (2014) 1.03
Case-control study of Merkel cell polyomavirus infection and cutaneous squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev (2011) 1.02
Telomere length and risk of melanoma, squamous cell carcinoma, and basal cell carcinoma. Cancer Epidemiol (2013) 0.96
Vemurafenib and radiosensitization. JAMA Dermatol (2013) 0.95
A new spectrum of skin toxic effects associated with the multikinase inhibitor vandetanib. Arch Dermatol (2012) 0.94
Systemic retinoids for chemoprevention of non-melanoma skin cancer in high-risk patients. J Drugs Dermatol (2010) 0.94
Surgical management of melanoma in situ on chronically sun-damaged skin. Cancer Control (2008) 0.93
Case-control study of smoking and non-melanoma skin cancer. Cancer Causes Control (2011) 0.93
Case-control study of genus-beta human papillomaviruses in plucked eyebrow hairs and cutaneous squamous cell carcinoma. Int J Cancer (2013) 0.91
Sensitive skin in the American population: prevalence, clinical data, and role of the dermatologist. Int J Dermatol (2011) 0.89
The surgical management of primary and metastatic Merkel cell carcinoma. Curr Probl Cancer (2010) 0.89
[Bullous pemphigoid, primary biliary cirrhosis and vitiligo: a multiple autoimmune syndrome?]. Ann Med Interne (Paris) (2002) 0.87
Case-control study of cutaneous human papillomavirus infection in Basal cell carcinoma of the skin. J Invest Dermatol (2013) 0.87
Melanomas Associated With Blue Nevi or Mimicking Cellular Blue Nevi: Clinical, Pathologic, and Molecular Study of 11 Cases Displaying a High Frequency of GNA11 Mutations, BAP1 Expression Loss, and a Predilection for the Scalp. Am J Surg Pathol (2016) 0.86
Mycosis fungoides-type cutaneous T-cell lymphoma and neutrophilic dermatosis. Arch Dermatol (2005) 0.86
Sensitive scalp: does this condition exist? An epidemiological study. Contact Dermatitis (2008) 0.85
Regulation of CD4(+)NKG2D(+) Th1 cells in patients with metastatic melanoma treated with sorafenib: role of IL-15Rα and NKG2D triggering. Cancer Res (2013) 0.84
Sunlight exposure and cutaneous human papillomavirus seroreactivity in basal cell and squamous cell carcinomas of the skin. J Infect Dis (2012) 0.84
Patterns and timing of sunlight exposure and risk of basal cell and squamous cell carcinomas of the skin--a case-control study. BMC Cancer (2012) 0.83
Family burden in inherited ichthyosis: creation of a specific questionnaire. Orphanet J Rare Dis (2013) 0.83
Immunohistochemical stains in Mohs surgery: a review. Dermatol Surg (2009) 0.83
Severe meningo-radiculo-neuritis associated with ipilimumab. Invest New Drugs (2012) 0.82
The contribution of large genomic deletions at the CDKN2A locus to the burden of familial melanoma. Br J Cancer (2008) 0.81
Multiple keratoacanthomas arising in the setting of sorafenib therapy: novel chemoprophylaxis with bexarotene. Cancer Control (2009) 0.80
Defining the clinical condition of cancer patients: it is time to switch from performance status to nutritional status. Support Care Cancer (2011) 0.79
Sentinel lymph node biopsy in melanoma: Facts and controversies. Clin Dermatol (2010) 0.79
Management of familial melanoma and nonmelanoma skin cancer syndromes. Surg Oncol Clin N Am (2009) 0.79
Rapid frozen section immunostaining of melanocytes by microphthalmia-associated transcription factor. Am J Dermatopathol (2010) 0.79
A systematic review of patient-reported outcome instruments of dermatologic adverse events associated with targeted cancer therapies. Support Care Cancer (2015) 0.78
[Screening and early diagnosis of other cancers (non-small cell lung carcinoma, urologic cancers, liver cancer and melanoma)]. Rev Prat (2010) 0.78
Correlation of phenotype/genotype in a cohort of 23 xeroderma pigmentosum-variant patients reveals 12 new disease-causing POLH mutations. Hum Mutat (2014) 0.78
Distinction of melanoma in situ from solar lentigo on sun-damaged skin using morphometrics and MITF immunohistochemistry. Am J Dermatopathol (2011) 0.78
Recurrent superficial mucoceles associated with lichenoid disorders. J Oral Maxillofac Surg (2006) 0.78
Sensitive skin evaluation in the Japanese population. J Dermatol (2012) 0.78
A new ten-item questionnaire for assessing sensitive skin: the Sensitive Scale-10. Acta Derm Venereol (2014) 0.77
Chemotherapy-Related Reticulate Hyperpigmentation: A Case Series and Review of the Literature. Dermatology (2015) 0.77
Erratum: anticancer immunotherapy by CTLA-4 blockade: obligatory contribution of IL-2 receptors and negative prognostic impact of soluble CD25. Cell Res (2015) 0.77
CosmeceutiQoL: a tool for assessing dermo-cosmetic products' impact on quality of life. J Cosmet Laser Ther (2012) 0.76
The role of maintenance phototherapy in cutaneous T-cell lymphoma. J Drugs Dermatol (2010) 0.76
The role of phototherapy in cutaneous T-cell lymphoma. J Drugs Dermatol (2010) 0.76
Rapid immunostaining in Mohs: current applications and attitudes. Dermatol Surg (2012) 0.75
Concurrent radiotherapy for patients with metastatic melanoma and receiving anti-programmed-death 1 therapy: a safe and effective combination. Melanoma Res (2017) 0.75
Mohs surgery for melanoma: rationale, advances and possibilities. Expert Rev Anticancer Ther (2011) 0.75
Discussing sentinel lymph node biopsy with your melanoma patients. J Drugs Dermatol (2010) 0.75
Advances in immunostains used in Mohs surgery. J Drugs Dermatol (2010) 0.75
Development of Papulopustular Rosacea during Nivolumab Therapy of Metastatic Cancer. Acta Derm Venereol (2016) 0.75
Scurvy in liver transplant patients. J Am Acad Dermatol (2006) 0.75
Paronychia and pyogenic granuloma induced by new anticancer mTOR inhibitors. Acta Derm Venereol (2011) 0.75
Acute Lower Limb Ischaemia and Diabetes in a Patient Treated with Anti-PD1 Monoclonal Antibody for Metastatic Melanoma. Acta Derm Venereol (2017) 0.75
Melanoma arising from a long-standing pigmented trichoblastoma: clinicopathologic study with complementary aCGH/mutational analysis. Am J Dermatopathol (2014) 0.75
[Cutaneous effects related to the use of tyrosine kinase inhibitors]. Rev Pneumol Clin (2007) 0.75
A comprehensive guide to the surgical management of nonmelanoma skin cancer. Curr Probl Cancer (2015) 0.75
Scoring of Mohs tissue in one-piece processing to prevent tissue crumbling or detachment from the embedding medium while sectioning. Dermatol Surg (2009) 0.75
Efficacy and safety of a new topical keratolytic treatment for localized hyperkeratosis in adults. J Drugs Dermatol (2010) 0.75
A unique basaloid proliferation encountered during Mohs surgery: potential pitfall for overdiagnosis of basal cell carcinoma. Dermatol Surg (2011) 0.75